Factors associated with adverse cardiovascular events in cancer patients treated with bevacizumab
- Ngo, Doan T. M., Williams, Trent, Horder, Sophie, Kritharides, Leonard, Vardy, Janette, Mandaliya, Hhiren, Nordman, Ina I. C., Lynam, James, Bonaventura, Tony, Sverdlov, Aaron L.
Heart Failure in Breast Cancer Survivors: Focus on Early Detection and Novel Biomarkers
- Chen, Dongqing, Kelly, Conagh, Haw, Tatt Jhong, Lombard, Janine M., Nordman, Ina I. C., Croft, Amanda J., Ngo, Doan T. M., Sverdlov, Aaron L.
Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)
- Mandaliya, Hiren, Jones, Mark, Oldmeadow, Christopher, Nordman, Ina I. C.
Are you sure you would like to clear your session, including search history and login status?